Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates

Background: Patent ductus arteriosus (PDA) is a common disease in premature neonates, which could occur in up to 50% of the neonates weighting <1000 g. PDA might induce hemodynamic and respiratory disorders and increase mortality and morbidity. This study aimed to compare the effectiveness of ora...

Full description

Bibliographic Details
Main Authors: Mehdi Ghaderian, Amir Mohammad Armanian, Mohammad Reza Sabri, Mojtaba Montaseri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=13;epage=13;aulast=Ghaderian
id doaj-7f8b3479bf6449579f3f22050daa2a92
record_format Article
spelling doaj-7f8b3479bf6449579f3f22050daa2a922020-11-25T01:30:46ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362019-01-01241131310.4103/jrms.JRMS_631_17Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonatesMehdi GhaderianAmir Mohammad ArmanianMohammad Reza SabriMojtaba MontaseriBackground: Patent ductus arteriosus (PDA) is a common disease in premature neonates, which could occur in up to 50% of the neonates weighting <1000 g. PDA might induce hemodynamic and respiratory disorders and increase mortality and morbidity. This study aimed to compare the effectiveness of oral ibuprofen and a low dose of intravenous acetaminophen in the management of PDA. Materials and Methods: This randomized double-blind clinical trial was conducted on the preterm neonates with an equal gestational age of <34 weeks and weight of >1000 g with symptomatic PDA, who were admitted in Shahid Beheshti and Al-Zahra Hospitals Affiliated to Isfahan University of Medical Sciences, Iran. In total, 40 preterm neonates were examined, 20 of whom received 15 mg/kg/6 h of intravenous acetaminophen for 2 days and 20 infants received 10 mg/kg of intravenous ibuprofen on the 1st day and 5 mg/kg for the next 2 days, and the results include vital signs and echocardiography findings were compared. Results: In the acetaminophen and ibuprofen groups, 16 (80%) and 17 neonates (85%) responded (PDA closure rate) to the treatment, respectively (P = 0.68). Furthermore, acetaminophen and ibuprofen have a similar effect on vital signs. Both drugs did not change in blood pressure, but they reduced the respiratory rate and heart rate after treatment. Conclusion: Low-dose acetaminophen compared to ibuprofen has an equal effectiveness in the closure of PDA.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=13;epage=13;aulast=Ghaderianacetaminophenductus arteriosusibuprofenpreterm
collection DOAJ
language English
format Article
sources DOAJ
author Mehdi Ghaderian
Amir Mohammad Armanian
Mohammad Reza Sabri
Mojtaba Montaseri
spellingShingle Mehdi Ghaderian
Amir Mohammad Armanian
Mohammad Reza Sabri
Mojtaba Montaseri
Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
Journal of Research in Medical Sciences
acetaminophen
ductus arteriosus
ibuprofen
preterm
author_facet Mehdi Ghaderian
Amir Mohammad Armanian
Mohammad Reza Sabri
Mojtaba Montaseri
author_sort Mehdi Ghaderian
title Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
title_short Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
title_full Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
title_fullStr Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
title_full_unstemmed Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
title_sort low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
publisher Wolters Kluwer Medknow Publications
series Journal of Research in Medical Sciences
issn 1735-1995
1735-7136
publishDate 2019-01-01
description Background: Patent ductus arteriosus (PDA) is a common disease in premature neonates, which could occur in up to 50% of the neonates weighting <1000 g. PDA might induce hemodynamic and respiratory disorders and increase mortality and morbidity. This study aimed to compare the effectiveness of oral ibuprofen and a low dose of intravenous acetaminophen in the management of PDA. Materials and Methods: This randomized double-blind clinical trial was conducted on the preterm neonates with an equal gestational age of <34 weeks and weight of >1000 g with symptomatic PDA, who were admitted in Shahid Beheshti and Al-Zahra Hospitals Affiliated to Isfahan University of Medical Sciences, Iran. In total, 40 preterm neonates were examined, 20 of whom received 15 mg/kg/6 h of intravenous acetaminophen for 2 days and 20 infants received 10 mg/kg of intravenous ibuprofen on the 1st day and 5 mg/kg for the next 2 days, and the results include vital signs and echocardiography findings were compared. Results: In the acetaminophen and ibuprofen groups, 16 (80%) and 17 neonates (85%) responded (PDA closure rate) to the treatment, respectively (P = 0.68). Furthermore, acetaminophen and ibuprofen have a similar effect on vital signs. Both drugs did not change in blood pressure, but they reduced the respiratory rate and heart rate after treatment. Conclusion: Low-dose acetaminophen compared to ibuprofen has an equal effectiveness in the closure of PDA.
topic acetaminophen
ductus arteriosus
ibuprofen
preterm
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=13;epage=13;aulast=Ghaderian
work_keys_str_mv AT mehdighaderian lowdoseintravenousacetaminophenversusoralibuprofenfortheclosureofpatentductusarteriosusinprematureneonates
AT amirmohammadarmanian lowdoseintravenousacetaminophenversusoralibuprofenfortheclosureofpatentductusarteriosusinprematureneonates
AT mohammadrezasabri lowdoseintravenousacetaminophenversusoralibuprofenfortheclosureofpatentductusarteriosusinprematureneonates
AT mojtabamontaseri lowdoseintravenousacetaminophenversusoralibuprofenfortheclosureofpatentductusarteriosusinprematureneonates
_version_ 1725090089899393024